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Abstract
Rationale—Congenital heart defects (CHD) represent the most common human birth defects. Even
though the genetic cause for these syndromes has been linked to respective candidate genes, the
underlying molecular mechanisms are still largely unknown. Disturbance of neural crest cell (NCC)
migration into the derivatives of the pharyngeal arches and pouches can account for many of the
developmental defects.
Objective—To investigate the function of miRNA in NCCs and cardiovascular system.
Methods and Results—we deleted Dicer from neural crest cell (NCC) lineage and showed that
Dicer conditional mutants exhibit severe defects in multiple craniofacial and cardiovascular
structures, many of them are observed in human NCCS patients. We found that cranial NCCs require
Dicer for their survival and deletion of Dicer led to massive cell death and complete loss of NCC-
derived craniofacial structures. In contrast, Dicer and miRNAs were not essential for the survival of
cardiac NCCs. However, the migration and patterning of these cells were impaired in Dicer knockout
mice, resulting in a spectrum of cardiovascular abnormalities, including Type B Interrupted Aortic
Arch (IAA-B), Double Outlet Right Ventricle (DORV) and Ventricular Septal Defect (VSD). We
show that Dicer loss-of-function was, at least in part, mediated by miR-21 and miR-181a, which in
turn, repressed the protein level of Sprouty 2, an inhibitor of Erk1/2 signaling.
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Conclusion—Our results uncovered a central role for Dicer and miRNAs in neural crest cells
survival, migration and patterning in craniofacial and cardiovascular development which, when
mutated, lead to congenital neuro-craniofacial-cardiac defects.
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Introduction
Congenital heart diseases are present in about 1 percent of live births and are the leading cause
of human congenital birth defects. The pathogenesis of congenital heart disease is varied and
the genetic cause of disease remains to be completely understood. Intriguingly, phenotypic
overlap between genetic disorders in cardiovascular and neuronal-craniofacial defects,
including DiGeorge Syndrome (DGS), Noonan syndrome, LEOPARD syndrome, cardio-
facio-cutaneous (CFC) syndrome, and Costello syndrome, has been described1, 2. DGS is
caused by a deletion of 3 million base pairs on one copy of chromosome 223, 4. Genetic studies
in mouse have shown that heterozygous deletion of Tbx1, a gene located in the deleted region
of 22q11, causes a DGS-like phenotype5–7. However, signals downstream of Tbx1 which
mediate DGS phenotype remain unclear. Genetic studies have linked ~50% of Noonan
syndrome to mutations in PTPN11 gene, which encodes SHP-2 protein, an SH2 domain-
containing, non-receptor tyrosine phosphatase (PTPase) essential for cellular proliferation,
differentiation and migration8. Numerous human genetic studies revealed that mutations in the
components of the RAS/RAF/MEK/ERK signaling cascade, which are key elements of a major
intracellular signal transduction pathway involved in essential biological processes, were
associated with many of the above-mentioned neuronal-craniofacial-cardiovascular
syndromes9. Genetic studies in animal models in which the components of the signaling
cascade were deleted, conventionally or in a spatiotemporal-specific manner, further support
this view10.
The development of outflow tract and aorticpulmonary arteries is a complex process which
involves precise regulation of cell proliferation, differentiation, migration and apoptosis of
cells derived from multiple sources. Perturbation of this developmental process is often
associated with congenital cardiovascular defects11. Neural crest cells (NCCs) are a transient,
migratory population of progenitor cells that give rise to many cell types, including vascular
smooth muscle cells, chondrocytes, melanocytes and neurons12. Cranial NCCs, a subset of
NCCs, which migrate into 1st and 2nd pharyngeal arches, give rise to cranial ganglia, the
maxilla, the mandible as well as muscle and cartilage of the head and neck13. Cardiac NCCs,
another subset of NCCs that migrate into the 3rd, 4th and 6th pharyngeal arches, populate the
aorticpulmonary septum and conotruncal cushion. They also contribute to the development of
smooth muscle of great vessels14. Cardiac NCCs have long been known to be essential for
proper development and patterning of great arteries and for outflow tract septation. Ablation
of NCCs during early embryogenesis resulted in severe defects in cardiovascular
structures11. However, signals that are necessary for the proper NCC development, patterning,
survival and migration are not completely understood15, 16.
miRNAs are a class of ~22 nucleotide non-coding RNAs that regulate gene expression post-
transcriptionally17. Despite the identification of large number of miRNAs18, the biological
roles of most miRNAs and the molecular mechanisms underlying their function remain largely
unknown. Dicer is an endonuclease required for miRNA biogenesis and the maturation of
miRNAs19. Our previous studies revealed an essential role of Dicer and miRNAs in normal
heart formation and function20. Recent reports documented that NCC-expressed miRNAs are
essential for the development of craniofacial structure 21, 22. In the present study, we generated
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neural-crest-cell-specific Dicer mutant mice. Targeted deletion of Dicer in NCCs resulted in
severe defects in craniofacial structures and malformation of cardiovascular system, including
ventricular septal defects, double outlet right ventricle and type B interrupted aortic arch. Our
studies demonstrated that Dicer is required for the survival of cranial NCCs, whereas deletion
of Dicer in cardiac NCCs altered their migration, patterning and the morphogenesis of aortic
arch arteries and outflow tract.
Results
Neural-crest-cell-specific Dicer mutant mice are perinatal lethal
To investigate the role of Dicer and miRNAs in the development of neural crest cell (NCC)
lineage, we deleted Dicer in NCCs. We bred the Dicer-floxP mice, in which the 22nd and
23rd exons of Dicer gene are flanked by two loxP sites23, with a Wnt1-Cre transgenic mouse
line (Supplemental Figure IA). The Wnt1-cre displayed robust Cre recombinase activity in
NCC lineage as early as embryonic day 9.5 (E9.5), as evidenced by the Rosa-LacZ indicator
mice (Supplemental Figure IB), consistent with a previous report24. Mice with heterozygous
deletion of Dicer in NCCs (Wnt1-Cre/Dicerflox/+) were fertile and exhibited no apparent
abnormalities. However, homozygous mutant mice (Wnt1-Cre/Dicerflox/flox) were found dead
shortly after birth with no exception. Genotyping of 228 embryos at different developmental
stages identified the Mendelian ratio for all four expected genotypes (Supplemental Table I),
indicating that NCC-specific deletion of Dicer did not result in embryonic lethality. qRT-PCR
and Western blot analyses using samples from pharyngeal arches of E11.5 mutant embryos
confirmed a dramatic reduction of Dicer expression (Supplemental Figure IC, ID). We could
still detect residual Dicer expression level, primarily because pharyngeal arch tissues also
contain non-NCC cell lineage. These data demonstrate that Dicer is indispensable for the
development of NCCs.
Neural-crest-cell-specific Dicer mutant mice display severe craniofacial defects
All neural-crest-cell-specific-Dicer (herein referred to as NCC-Dicer) mutants exhibit severe
craniofacial defects with 100% penetrance. These defects include the complete absence of
maxilla, nose, mandible, external ear and eyelid at E17.5 (Figure 1A, arrows). Skeletal
preparation of E17.5 embryos clearly demonstrated developmental defects of craniofacial
skeleton and cartilage in NCC-Dicer mutants. As shown in Figure 1B (arrows), the maxilla,
mandible and nasal bones are completely absent in mutant embryos. Moreover, most neural-
crest-derived cartilages, including Meckel’s cartilage, hyoid, thyroid cartilage and tracheal
cartilages, did not form in NCC-Dicer mutants (Figure 1B). In addition to contributing to the
development of craniofacial structures, NCCs are also known to contribute to the development
of thymus and parathyroid glands25. Accordingly, we observed that NCC-Dicer mutant
embryos displayed hypoplastic thymus and the parathyroid glands were underdeveloped
(Figures 1C, D, arrows). Our data therefore established Dicer as an essential factor for the
development of NCC-derived structures and are consistent with recent reports 21, 22.
Next, we sought to determine the developmental timing of craniofacial defects found in NCC-
Dicer mutants. Cranial NCCs migrate through the 1st and 2nd pharyngeal arches (PAs) to give
rise to many of the craniofacial structures26. We examined the proliferation, apoptosis and
migration of cranial NCCs in NCC-Dicer mutant embryos. There was no difference in cell
proliferation of cranial NCCs in E10.5 NCC-Dicer mutant embryos, when compared with
controls (Supplemental Figure II). However, massive apoptosis occurred in the 1st and 2nd PAs
as early as E10.5 in NCC-Dicer mutant embryos, evidenced by a significant increase in TUNEL
staining (Figure 1E). Increased apoptosis in 1st and 2nd PAs was further confirmed by the
increased signal of cleaved-caspase 3 (Supplemental Figure III). In addition, whole-mount Nile
blue sulfate (NBS) was applied in E10.5 embryos to further demonstrate an increased apoptosis
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in NCC-Dicer mutant embryos (Figure 1G). As a consequence, the 1st and 2nd PAs of NCC-
Dicer mutant embryos were substantially smaller than that of the controls. (Figure 1H). NCC-
Dicer mutant embryos failed to form the lateral lingual swellings in mandibular portion of the
1st pharyngeal arch (Figure 1I, arrows), and there was a dramatic decrease in the formation of
tongue (Figure 1L). Despite the increased apoptosis in cranial NCCs, the overall
morphogenesis of the 1st and 2nd PAs was not significantly affected in E10.5 NCC-Dicer
mutant embryos, evidenced by a normal PECAM staining pattern, which marks in the
pharyngeal endothelium (Supplemental Figure IV). At E13.5, NCC-Dicer mutant embryos also
displayed a cleft lip (Figure 1J, arrows) and hypoplastic pinna (Figure 1K, arrows).
Interestingly, the development of cartilage primordium of clivus, which is not derived from
cranial NCCs, was unaffected in NCC-Dicer mutant embryos (Figure 1L, arrows),
demonstrating the specificity of defects. Finally, we examined the development of neural-crest-
derived cranial ganglia in DCC-Dicer mutant embryos. We found that the development of
ganglion of cranial nerve V, revealed by whole mount immunostaining using an anti-
neurofilament antibody, was slightly affected at E10.5, however, such defects become more
profound in E13.5 NCC-Dicer mutant embryos (Supplemental Figure V). These data
demonstrate that Dicer is indispensable for the survival of cranial NCC progenitor cells and
NCC-specific deletion of Dicer severely perturbed the proper development of neural-crest-
derived craniofacial structures in a cell-autonomous manner.
NCC-specific Dicer mutation leads to multiple cardiovascular defects
Cardiac NCCs migrate into the embryonic heart field and contribute to the development of
aortic arch arteries and outflow tract. It is therefore not surprising that NCC-Dicer mutant
embryos exhibited multiple cardiovascular defects (Figure 2A). All NCC-Dicer mutant
embryos examined displayed interrupted aortic arch (IAA) at E17.5 (n=7), in which the aortic
arch is not connected to the descending aorta (Figure 2B, arrows). Histological examination
also revealed ventricular septal defect (VSD) in the heart of all NCC-Dicer mutant embryos
(Figure 2C). We found that all NCC-Dicer mutant embryonic hearts displayed double outlet
right ventricle (DORV), in which the right ventricle was connected to both the pulmonary
artery and aorta (Figure 2D). In order to view aortic artery defects in more detail, we injected
ink into the ventricle of E17.5 embryonic hearts. This allowed us to clearly define a Type B
interrupted aortic arch (IAA-B), in which the aortic arch is interrupted between the common
carotid artery and the left subclavian artery, in NCC-Dicer mutant embryos (Figure 2E), In
addition, about 50% of NCC-Dicer mutant embryos exhibited retroesophageal right subclavian
artery (RRSA), in which a right subclavian artery ectopically originated from descending aorta
instead of innominate artery and extended rightward behind esophagus (Figure 2E).
Histological sections further confirmed RRSA in the NCC-Dicer mutant embryos (Figures 2F,
G). Furthermore, NCC-Dicer expression is required for the correct position and patterning of
the carotid arteries and thymus. As shown in Figure 2, both carotid arteries, the left carotid
artery (LCA) and right carotid artery (RCA), were misplaced in NCC-Dicer mutant embryos:
instead of lying behind the thymus as in the normal control embryos, both carotid arteries were
found passing through the thymus in NCC-Dicer mutant embryos (Figure 2F). Together, our
data established that Dicer played a crucial role in cardiac NCCs and is required for the proper
development of NCC-derived cardiovascular system.
Distinct requirement for Dicer and miRNAs in cranial and cardiac NCC development
NCC-Dicer mutant mice displayed defects in craniofacial and cardiovascular development.
However, the severity of defects was quite distinct, loss-of-Dicer in NCCs led to almost
complete absence of craniofacial structures, whereas the defects in cardiovascular system were
less severe and were primarily associated with patterning disorders. We asked whether there
was a distinct requirement for Dicer and miRNAs in cranial versus cardiac NCCs during
development. Cranial NCCs primarily migrate through the 1st and 2nd PAs and Dicer is required
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for their survival (Figures 1E, F, G). In contrast, cardiac NCCs migrate into the outflow tract,
primarily through the 3rd, 4th and 6th PAs, to form the aorticopulmonary septum, and two prongs
of cardiac NCCs will further extend to anterior heart field and contribute to the closure of
ventricular septum27. To track the migration of NCCs, the Rosa-LacZ indicator was introduced
into NCC-Dicer mutant mice. Whole mount β-gal staining revealed that NCC-specific deletion
of Dicer did not prevent NCCs from migrating into all pharyngeal arches and the outflow tract
at E11.5 (Figure 3A and Supplemental Figures VI A, B). Next, we examined whether NCC-
Dicer mutant embryos displayed defects in their proliferation or apoptosis in cardiac NCC-
derived structures. Interestingly, no aberrant cellular proliferation or apoptosis was found in
the 3rd, 4th and 6th PAs or in the outflow tract of E10.5 NCC-Dicer mutant embryos
(Supplemental Figures VI C–F). This is in sharp contrast to the dramatic increase of apoptosis
detected in the 1st and 2nd PAs (Figures 1E–G). However, the migration pattern of cardiac
NCCs in the outflow tract was altered in NCC-Dicer mutant embryos (Figures 3B, D). At
E11.5, Dicer-deficient cardiac NCCs failed to form two columns of condensed conotruncal
cushion in the outflow tract, when compared to wildtype controls (Figure 4B, arrows). In
addition, a malalignment between the outflow tract entrance for future aorta and the muscular
interventricular septum occurred in NCC-Dicer mutant mice (Figure 3C). At E13.5, two prongs
of cardiac NCCs, which are normally aligned with ventricular septum in a fore-and-aft position,
rotated improperly and were located in right ventricle in a side-by-side manner, leading to a
malalignment with ventricular septum in mutant mice (Figure 3D). The aberrant rotation and
malalignment of conus cushion between E11.0 to E12.5 have been reported to result in VSD
and DORV28. Our data suggested that abnormal migration and patterning of cardiac NCCs in
outflow tract led to the rotation and alignment defects of conus cushion, which eventually
contribute to the VSD and DORV defects observed in NCC-Dicer mutant mice.
The defective development of 4th pharyngeal arch (PA) is often associated with the type B IAA
in congenital heart disease29. To investigate the etiology of type B IAA found in NCC-Dicer
mutant mice, we examined the morphogenesis of the 4th PA during the outflow tract remodeling
in wildtype controls and NCC-Dicer mutant embryos. No obvious defect of 4th PAA was found
in E10.5 NCC-Dicer mutant embryos, when compared with that of wildtype controls
(Supplemental Figure IV). However, a hypoplastic aortic arch artery became evident in E13.5
NCC-Dicer mutant embryos (Figure 3E, arrows). Histology analyses clearly demonstrated
much thinner vessel wall in the aortic arch artery of NCC-Dicer mutant embryos, when
compared with controls (Figures 3E’, E’’ and Supplemental Figure VII). TUNEL assays further
revealed an increased apoptosis in the aortic arch artery of NCC-Dicer mutant embryos (Figures
3F, G). We noticed that apoptosis only occurred at a restricted region of the aortic arch artery
and no increase in apoptosis was observed in the ascending aorta or carotid arteries of mutant
embryos. These observations suggested that apoptosis occurred in the developing aortic arch
artery likely contributed to IAA-B of NCC-Dicer mutant embryos. These data further suggest
that there is a distinct requirement for Dicer and miRNAs during the development of the 4th
versus 3rd/6th PAs during outflow tract remodeling.
Next, we examined whether loss of Dicer in NCCs affected the specification of vascular smooth
muscle cell (SMC) fate and the morphogenesis of aortic arch arteries. Immunohistochemistry
using smooth muscle markers, including smooth muscle actin (SM-actin) and SM-α-22,
demonstrated that SMC differentiation was not affected in NCC-Dicer mutant aortic arteries
(Supplemental Figure VIII). However, deletion of Dicer from NCCs appeared to affect the
assembly of smooth muscles in aortic arch arteries (Supplemental Figure IX). The ascending
aorta, but not the descending aorta (which is not derived from cardiac NCCs), displayed fewer
layers of smooth muscle cells in E17.5 NCC-Dicer mutant embryos (Supplemental Figure IX).
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Dicer and miRNAs participate the MEK/ERK signaling cascade to regulate neural crest cell
and pharyngeal arch artery development
Signal transduction pathways, in particular the MEK/ERK cascade, play a central role in cell
proliferation, differentiation, migration and survival30. Recent studies established that
components of this signaling cascade are important for the development of NCCs10.
Dysregulation of their expression or genetic mutations of members of this signaling pathway
have been associated with human congenital birth defects31. Targeted deletion of MEK or
ERK1/2 in mouse NCCs led to severe craniofacial and cardiovascular defects, reminiscent that
of NCC-Dicer mutant mice10. We examined the expression level of ERK proteins in NCC-
Dicer mutant embryos. Whole mount immunostaining, examined by confocal microscopy,
showed that the expression of phosphorylated Erk1/2 (pErk1/2) was significantly decreased in
the pharyngeal arches (PAs) of E10.5 and E11.5 NCC-Dicer mutant embryos (Figures 4A, B).
Western blot analyses further demonstrated a decreased expression level of pErk1/2 proteins
in the PAs of E11.5 NCC-Dicer mutant embryos (Figure 4D). To confirm the above
observation, additional immunohistochemistry was performed on E10.5 embryonic sections.
Indeed, the expression of pErk1/2 was dramatically decreased in the 1st PA (Figure 4E). We
also examined the expression level of total Erk1/2 proteins and found that it was not
significantly altered in mutant embryos (data not shown). Notably, the expression level of
pErk1/2 proteins did not change in the limb buds of NCC-Dicer mutant embryos (Figure 4A),
suggesting that the decreased pErk1/2 expression in the NCC-derived structure is due to the
loss of Dicer and miRNAs.
miRNAs are known to repress the expression of their target genes, primarily by degrading the
target mRNAs and/or inhibiting their translation18. The observation that pErk1/2 expression
level was significantly decreased in the PAs of NCC-Dicer mutant embryos suggested that
Erk1/2 is unlikely a direct target of miRNAs in this setting. We speculated that increased
expression of a negative regulator/inhibitor of the ERK signaling could explain the observation.
Interestingly, sprouty proteins have been characterized as intrinsic inhibitors of the MEK/ERK
pathway32. We tested the expression level of sprouty proteins and found that the expression
of sprouty2 was significantly increased in NCC-Dicer mutant pharyngeal arches (Figure 4C).
Immunostaining using tissue sections confirmed the increase of sprouty1/2 protein level in the
1st PA of NCC-Dicer mutant embryos (Figures 4F, G). Increased sprouty2 expression in NCC-
Dicer mutant embryonic PAs was further quantified by Western blot analyses (Figure 4D). We
examined the expression of additional components of the MEK/ERK signaling pathway in PAs
of NCC-Dicer mutant embryos. Whereas the expression levels of Crkl and SHP2 appeared not
affected (Figures 4H, I), the protein levels for SOS1 and pMEK1/2 were decreased in NCC-
Dicer mutant embryos (Figures 4J, K).
Searching for miRNAs that target sprouty proteins, we found that miR-21 and miR-181a are
putative repressors. Interestingly, a recent report showed that miR-21 inhibited the expression
level of sprouty1 in cardiac fibroblasts, leading to cardiac hypertrophy and fibrosis33. We
examined the expression of miR-21 and miR-181a and found that both miRNAs were expressed
in the PAs of E11.5 mouse embryos (Figure 5A). Most importantly, the expression level of
mature miRNAs was significantly decreased, accompanying with an accumulation of their
precursor miRNAs in the PAs of NCC-Dicer mutants (Figure 5A). Quantitative real-time PCR
assays further confirm the reduction of mature miR-21 and miR-181a level (Figure 5B). Such
a decreased miR-21 and miR-181a expression inversely correlated with an increased protein
level of their target gene, sprouty2. In order to directly test whether miR-21 and miR-181a
could repress the expression of sprouty genes, we constructed two repeats of the predicted
miR-21 or miR-181a target sequences from the 3’UTRs of indicated sprouty genes downstream
of a luciferase gene (Luc-Spry) and co-transfected with miRNA mimics. We have also included
Luc-miR-21-sensor and Luc-miR-181a–sensor to serve as controls for miRNA-mediated
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repression. Transfection of either miR-21 mimic or miR-181a mimic repressed luc-Spry
luciferase activity (Figure 5C), suggesting that miR-21 and miR-181a specifically target
sprouty genes at 3’ UTRs.
Discussion
Neural crest cells are one of the most important embryonic progenitor cells which can give rise
to multiple cell and tissue types, including that of the craniofacial structures and the great
arteries, during vertebrate development12. In this study, we demonstrated that Dicer and
miRNAs are essential for the development of neural crest cells. Targeted deletion of Dicer in
neural crest cells led to severe craniofacial and cardiovascular defects, which are reminiscent
to features of human congenital neuro-craniofacial-cardiac defects. Our studies also suggested
that perturbation of MEK/ERK signaling pathway by miRNAs contributed to the
developmental defects.
The MEK/ERK signaling is one of the most important signal transduction pathways in
mammalian cells. Activated Erk1/2 can participate a broad array of cellular functions including
proliferation, survival, apoptosis, motility, transcription, metabolism and differentiation34–
36. Deregulation of its expression or inhibition of its activity was reported in many
developmental defects and pathophysiological conditions37–39. Furthermore, mutation in the
components of the MEK/ERK signaling cascade is associated with human disease31. Neural
crest cell-specific Erk1/2 double knockout mice displayed craniofacial and cardiovascular
defects10, similar to what we observed in NCC-specific Dicer mutant mice described in this
study. These observations suggest that inhibition of the ERK signaling pathway is likely
responsible for many of the developmental defects in NCC-Dicer mutant mice. Our studies
therefore implied that ERK signaling is regulated by miRNAs during neural crest development.
Indeed, recent reports showed that ERK activity was positively regulated by miR-2133, 40,
41.
The fact that most miRNAs negatively regulate the expression level of their target genes,
together with our observations in which deletion of Dicer (therefore the depletion of miRNAs)
resulted in a down-regulation of pErk level, strongly suggested to us that miRNAs in NCCs
likely directly targeted an inhibitor of the Erk signaling pathway, not the Erk itself. The Erk
signaling antagonist, Sprouty family members (Sprouty1, Sprouty2 and Sprouty4), are strong
inhibitors of the MEK/ERK signaling pathway, which can interfere with the MEK/ERK
signaling at many levels32. Indeed, our data showed that NCC-Dicer mutation resulted in an
increased level of Sprouty proteins and decreased expression of MEK1/2, ERK1/2. In this
sense, our results uncovered miRNAs as critical components of the feedback loop to modulate
the activities of RTK signaling in neural crest development (Figure 5D). Our data are consistent
with recent reports, for example, Sprouty133 and Sprouty241 have been reported to be regulated
by miR-21, whereas the Sprouy4 3’ UTR possesses two predicted miR-181a binding sites42.
Importantly, both miR-181a and miR-21 were highly expressed in NCCs, suggesting their
potential role there. Interestingly, targeted deletion of Dicer in limb mesenchyme led to
hypoplastic forelimb and hindlimb development43. Furthermore, Dicer-deficient limbs also
displayed a decrease in the expression level of pErk and an increase in sprouty2
expression43. These data further support the view that the relation between Dicer, miRNAs,
Sprouty2 and MEK/ERK signaling is common in the development of multiple organs.
miRNAs have emerged as a novel class of key regulators for gene expression in many biological
processes. Multiple studies have demonstrated distinct perturbations in miRNA expression
under various cardiac remodeling conditions and disease models44–50. However, there were
only very limited genetic studies to define the in vivo function of miRNA(s) in cardiovascular
system. Our studies provided genetic evidence to support the causal role of miRNAs in neural
Huang et al. Page 7













crest cells for the development of craniofacial and cardiovascular structures. Interestingly,
several recent studies reported that deletion of Dicer and depletion of miRNAs from vascular
smooth muscle cells or endothelial cells resulted in a variety of vascular development
defects51–53, further highlighting the central role of miRNAs in cardiovascular system. It will
be important for the future to determine the involvement of individual miRNAs in NCCs and
the development of aortic arch arteries. Given the profound defects revealed in this study, we
speculate that dysregulation and/or mutation in miRNA genes will be identified in human
patients with neural-cranial-facial-cardiac defects.
Materials and Methods
Generation of Dicer conditional null mice
Dicer floxed (Dicerflox/flox) mice23 and Wnt1-Cre transgenic mice24 have been described.
Dicerflox/flox/Wnt1-Cre mice were generated by breeding Dicerflox/flox mice with Wnt1-Cre
mice. To track the neural crest-derived cells, Rosa-lacZ reporter was introduced by breeding
Dicerflox/flox mice with Rosa-lacZ reporter mice54. Dicerflox/flox/Rosa-lacZflox/flox double
homozygous offsprings were used in the further mating with Dicerflox/flox/Wnt1-Cre mice. The
genotype of all the offsprings were determined by PCR using the following primers: Cre1: 5'-
GTTCGCAAGAACCTGATGGACA-3'; Cre2: 5'-CTAGAGCCTGTTTTGCACGTTC-3';
Dicer forward: 5'-ATTGTTACCAGCGCTTAGAATTCC-3'; Dicer reverse: 5'-
GTACGTCTACAATTGTCTATG-3'; R26R1: 5'-GCGAAGAGTTTGTCCTCAACC-3';
R26R2: 5'-GGAGCGGGAGAAATGGATATG-3'; R26R3: 5'-
AAAGTCGCTCTGAGTTGTTAT-3'.
Northern blot analyses, RT-PCR, TaqMan qPCR and Western blot analyses
Total RNAs were isolated using Trizol Reagent (Invitrogen) from wildtype or Dicer mutant
embryonic samples as indicated in figure legends. Northern blot detecting miRNAs was done
as described55. For RT-PCR, 2.0 µg RNA samples were reverse-transcribed to cDNA by using
random hexamers and MMLV reverse transcriptase (Invitrogen) in 20µl reaction system.
0.25µl cDNA pool was used per qPCR reaction. The sequences of the PCR primers are:
DicerRTF: 5’-AGCCGTTGAAGAGGATGACT-3’; DicerRTR: 5’-
CACACAGTCCGCTATGCTCT-3’. TaqMan-based quantitative real-time PCR was used to
measure the expression levels of mature miR-181a, miR-21 and was performed as
recommended by manufacturer (Applied Biosystem). Western blot analyses were performed
as described55 using protein extracts from embryonic samples as indicated in figure legends.
Histological examination, immunohistochemistry, Verhoeff's elastic staining and TUNEL
assay
Whole embryos and dissected tissues were fixed in 4% paraformaldehyde (pH 8.0) overnight.
After dehydration through a series of ethanol baths, samples were embedded in paraffin wax
according to standard laboratory procedures. Sections of 5 µm were stained with haematoxylin
and eosin (H&E) for routine histological examination with light microscope. For
immunohistochemistry, paraffin sections containing the structures of interest were selected.
After rehydration for paraffin sections, slides were heated in the 89°C in retrievagen A solution
(BD Pharmingen) for 10 min and washed in PBS for 5 min at room temperature. The remaining
steps for immunostaining were performed as previously described55. Sections were examined
and photographed using regular upright fluorescent microscope. Verhoeff's Elastic Staining,
showing the elastic fibre (in black), was performed as described56. TUNEL assay was
performed according to the protocol provided in ApopTag Fluorescein In Situ Apoptosis
Detection Kit (CHEMICON). At least three pairs of embryos (wildtype controls and mutants)
at the indicated developmental stages were used in each experiment.
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Whole mount immunostaining, β-gal staining and NBS staining
Embryos or tissues were carefully dissected out and rinsed for several times in ice-cold PBS.
Samples were fixed in fresh 4% paraformaldehyde (pH 8.0) at 4°C for 2 hours and washes with
PBS for more than 30 minutes. Whole mount immunostaining was performed as previously
described57. Samples were examined and photographed using confocal fluorescent
microscope. For β-gal staining, samples were stained with a solution containing 5 mM
potassium ferricyanide, 5 mM potassium ferrocyanide, and 1 mg/ml X-gal substrate at 37°C
for 2 to 4 hours before photographing. For whole mount Nile blue sulfate (NBS) staining, E10.5
embryos were dissected out and washed in PBS, and incubated for 1 hours at 37°C in filtered
NBS solution (10 mg/ml NBS (Sigma N-5632) in PBS containing 0.1% Tween 20). Embryos
were washed multiple times in PBS at room temperature and photographed immediately. At
least three pairs of embryos (wildtype controls and mutants) at the indicated developmental
stages were used in each experiment.
Skeleton preparation
Embryos were dissected out, fixed in 100% ethanol, skinned, and eviscerated, then stained
with alizarin red and alcian blue overnight at 37°C. Samples were cleared in 1% KOH for 10
hr, and then further incubated in 50:50 1% KOH/glycerol for several days before photography.
Antibodies
The primary antibodies used in this study include: Dicer (Abcam), β-tubulin(Sigma), Sprouty1
(Santa Cruz Biotechnology), Sprouty2 (Santa Cruz Biotechnology), phospho-Erk1/2 (Cell
Signaling), phosphor-MEK1/2 (Cell Signaling), Crkl (Santa Cruz Biotechnology), SHP-2
(Santa Cruz Biotechnology), Sos1 (Santa Cruz Biotechnology), smooth muscle 〈 22 (Abcam),
smooth muscle actin (Sigma), phospho-histone H3 (Upstate Biotechnology), cleaved-caspase
3 (Cell Signaling) and PECAM-1 (1:100, BD Pharmingen). Alexa Fluor secondary antibodies
were purchased from Invitrogen.
Luciferase reporter assays
A modified pGL3-control vector (pGL3cm) for 3′ UTR–luciferase reporter assays was
described previously55. The luc-Spry1, luc-Spry2, luc-Spry4-1 and luc-Spry4-2 luciferase
reporters were generated by annealing two tandem 40 bp repeat oligonucleotides from the 3’
UTR sequences of indicated sprouty genes which contain the predicted binding site for either
miR-21 or miR-181a. Since two miR-181a binding sites are presented in the 3’UTR of the
sprouty4 gene, two reporters, luc-Spry4-1 and luc-Spry4-2, were generated. We also generated
miRNA sensor constructs in which perfect complementary sequences against either miR-21
or miR-181a were cloned downstream of the luciferase reporter gene. Luciferase reporter
assays were performed using 24-well plates in Hela cells. All experiments were repeated at
least 3 times in triplicate. Unless otherwise indicated, transfection was performed using 25 ng
reporter plasmid and 150 or 450 ng miRNA duplex mimics. A Renilla luciferase vector was
used to serve as an internal control for normalization.
Statistics
Values are reported as means ± SEM unless indicated otherwise. The 2-tailed Mann-Whitney
U test was used for comparing 2 means (Prism; GraphPad). Values of P < 0.05 were considered
statistically significant.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Non-standard Abbreviations and Acronyms
CHD Congenital Heart Defects
DORV Double Outlet Right Ventricle
IAA Interrupted Aortic Arch
LCA Left Carotid Artery
NBS Nile Blue Sulfate
NCC Neural Crest Cell
NCCS Neuro-Craniofacial-Cardiac Syndromes
PA Pharyngeal Arch
RCA Right Carotid Artery
RRSA Retroesophageal Right Subclavian Artery
SMC Smooth Muscle Cell
VSD Ventricular Septal Defect
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Figure 1. Neural-crest-specific ablation of Dicer resulted in severe craniofacial defects
In all images, wild type (+/+) control and NCC-Dicer mutant (−/−) embryos are shown. (A)
Gross morphology of E17.5 embryos. Neural-crest-specific Dicer mutant embryos displayed
severe craniofacial defects (arrows). (B) Skeletal preparation of E17.5 embryos. Most of the
neural-crest-derived cartilages and bones, including maxilla, mandible and nasal bones
(arrows), were absent in Dicer mutants. (C) Thoracotomies showed the hypoplasia of thymus
(arrows) in mutant embryos. (D) Dicer mutant mice exhibited underdeveloped thyroid glands
(arrows). (E) TUNEL assay showed an abnormal apoptosis in the 1st (1PA) and 2nd (2PA)
pharyngeal arches in mutant embryos. (F) Statistics of TUNEL-positive cells. Three
discontinuous sections containing 1st and 2nd pharyngeal arches were stained and counted.
(G) Whole mount NBS staining consistently revealed the abnormal apoptosis in mutants. (H)
The morphology of 1st and 2nd pharyngeal arches of E10.5 embryos showed the reduced size
of pharyngeal arches in Dicer mutants. (I–K) Whole mount β-gal staining of E11.5 and E13.5
embryos containing Rosa-LacZ indicator. E11.5 Dicer mutant embryos failed to form the
lateral lingual swellings (I, arrows); E13.5 Dicer mutant embryos displayed a cleft lip (J,
arrows) and a hypoplastic pinna (K, arrows). (L) Histological examination of E13.5 embryonic
heads. The neural-crest-derived Meckel’s cartilage, hyoid cartilage and tooth primordium
failed to form in mutants, while the development of non-neural-crest-derived cartilage
primordium of clivus is unaffected. C: cartilage primordium of clivus; H: hyoid cartilage; M:
Meckel’s cartilage; T: tongue; TP: tooth primordium.
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Figure 2. Neural-crest-specific ablation of Dicer led to multiple cardiovascular defects
(A) The penetrance of cardiovascular defects displayed in Dicer mutant mice. (B) Gross
morphology of heart and great vessels from E17.5 embryos. The Dicer mutant mice exhibited
a type B interrupted aortic arch (arrow). (C–D) Histological examination of E17.5 embryonic
hearts. The mutant hearts possessed ventricular septal defect (C) accompanied with a double
outlet right ventricle (D). (E) Great vessels shown by ink injection. The type B interrupted
aortic arch was consistently found in mutant embryos. (F–G) Histological examination of
defects in great vessels. A right subclavian artery was ectopically originated from the
descending aorta (G) and extended rightward behind the esophagus (F, G). The asterisk in (G)
indicates the interruption of aortic arch. AAo: ascending aorta; Ao: aorta; AoA: aortic arch;
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DAo: descending aorta; DOSV: double outlet right ventricle; E: esophagus; H: heart; IA:
innominate artery; IAA: interrupted aortic arch; LA: left atrium; LCA: left carotid artery; LSA:
left subclavian artery; LV: left ventricle; Pa: pulmonary artery; RA: right atrium; RCA: right
carotid artery; RSA: right subclavian artery; RRSA: retroesophageal right carotid artery; RV:
right ventricle; T: trachea; Th: thymus; VSD: ventricular septal defect.
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Figure 3. Dicer and miRNAs are required for proper development of neural crest cells
(A) Whole mount β-gal staining of E11.5 embryos containing Rosa-LacZ indicator showed
the migration of cardiac neural crest to the caudal limit of outflow tract (arrows). (B)
Histological examination of the stained outflow tract. The Dicer-deficient cardiac NCCs failed
to form two columns of condensed mesenchyme in outflow tract. (C) Histological examination
of E11.5 heart. The entrance of outflow tract for future aorta (asterisks) had a rightward
malalignment with muscular interventricular septum. (D) Whole mount β-gal staining of E13.5
embryonic hearts indicated the rotation defect and malalignment of conus cushion. Two prongs
of Dicer-deficient cardiac NCCs (arrows) located in right ventricle in a side-by-side manner.
The dash lines indicate the ventricular septum. (E) Neural-crest-derived great vessels in E13.5
embryos were shown by β-gal staining. The blue lines in cartoon indicate the neural-crest-
derived vessels, while the red dash lines indicate the vessels not contributed by cardiac NCCs,
which cannot be shown in β-gal staining. Mutant embryos displayed a hypoplastic aortic arch
artery. Histological examination of aortic arch was performed in the orientation indicated by
dashed lines. The regions (E’, E’’) indicated by arrows were shown at bottom right and
Supplemental Figure VII. The aortic arch in mutant embryos had a thinner vessel wall with
fewer smooth muscle cells. (F) TUNEL assay with E13.5 embryo sections containing aortic
arch showed an abnormal apoptosis of neural-crest-derived smooth muscle cells in the vessels
in Dicer mutant embryos. (G) Statistics of TUNEL-positive cells. Three discontinuous sections
containing aortic arches were stained and counted. Ao: aorta; AoA: aortic arch; E: esophagus;
H: heart; LA: left atrium; LCA: left carotid artery; LSA: left subclavian artery; LV: left
ventricle; M: muscular interventricular septum; Pt: pulmonary trunk; RA: right atrium; RCA:
right carotid artery; RSA: right subclavian artery; RV: right ventricle; T: trachea.
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Figure 4. Dysregulation of gene expression of components in MEK/ERK signaling cascade in NCC-
Dicer mutants
(A–B) Whole mount immunochemistry detecting phospho-Erk1/2 (pErk1/2) in E10.5 (A, side
view) and E11.5 (B, frontal view) embryos. pErk1/2 was downregulated in neural-crest-derived
pharyngeal arches but not in limb buds of Dicer mutant embryos. (C) Whole mount
immunochemistry detecting Sprouty2 in E11.5 embryos. Sprouty2 was upregulated in neural-
crest-derived pharyngeal arches of Dicer mutant embryos. (D) The dysregulation of pErk1/2
and Sprouty2 was shown by Western blot with pharyngeal arch tissue samples. (E–K)
Examination of gene expression by immunohistochemistry detecting pErk1/2 (E), Sprouty1
(F), Sprouty2 (G), Crkl (H), SHP-2 (I), Sos1 (J) and pMEK1/2 (K) expression in first
Huang et al. Page 18













pharyngeal arches of E10.5 Dicer mutant embryos. 1PA: 1st pharyngeal arch; 2PA: second
pharyngeal arch; LB: limb bud.
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Figure 5. Repression of sprouty expression by miRNAs
(A) Detection of the haploinsufficiency of mature miRNAs and the accumulation of miRNA
precursors in mutant pharyngeal arch tissue samples by Northern blot. (B) Quantitative real-
time PCR assays to measure the expression level of mature miR-181a and miR-21 in mutant
pharyngeal arch tissues. *: P < 0.01. (C) Hela cells were transfected with indicated luciferase
reporters, along with either miR-21 or miR-181a duplex mimic. A Renilla luciferase vector
was cotransfected to serve as an internal control for normalization. Cells were harvested and
luciferase activity measured 24 hours after transfection. Values are presented as mean
luciferase activity ± SD relative to the luciferase activity of reporters with control duplex
mimic. *: P < 0.05. (D) Dicer and miRNAs are suggested to participate in a regulatory cascade
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to modulate the expression levels and activities of MEK/ERK signaling pathway in neural crest
cells.
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